Monte Rosa Therapeutics reported total assets of $691.16M and total liabilities of $203.88M for the quarter ended Jun 2026, up 92.2% year over year. This balance sheet covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 367.03M | 346.07M | 138.31M | 103.66M | 112.39M | 263.87M | 51.85M | 47.03M | 59.05M | 236.42M | 99.75M | 108.85M | 125.58M | 380.96M | 78.53M | 69.43M | 401.63M | 388.94M | 678.09M | 632.90M | |||||
| Short-term InvestmentsInvestments (Current) | 0.96M | 0.96M | 0.96M | ||||||||||||||||||||||
| Cash & Current Investments | 367.03M | 346.07M | 138.31M | 103.66M | 113.35M | 264.83M | 52.81M | 47.03M | 59.05M | 236.42M | 99.75M | 108.85M | 125.58M | 380.96M | 78.53M | 69.43M | 401.63M | 388.94M | 678.09M | 632.90M | |||||
| Receivables - NetNet Receivables | 9.00M | ||||||||||||||||||||||||
| Receivables - OtherOther Receivables | 4.05M | 0.01M | 2.17M | 1.15M | 0.29M | 0.34M | 0.60M | 0.84M | 0.59M | -0.42M | 1.41M | 2.37M | 4.96M | -0.36M | 4.61M | 4.92M | |||||||||
| Receivables | 9.84M | ||||||||||||||||||||||||
| Prepaid Assets | 3.48M | 2.60M | 3.20M | 2.90M | 4.57M | 4.44M | 5.69M | 3.88M | 4.14M | 3.29M | 5.54M | 5.85M | 8.43M | 5.12M | 4.80M | 6.50M | 5.59M | 4.48M | 6.72M | 5.38M | |||||
| Current Assets | 370.52M | 348.67M | 320.37M | 297.05M | 295.24M | 275.89M | 240.56M | 208.10M | 182.91M | 236.21M | 199.04M | 277.90M | 251.21M | 377.44M | 332.28M | 299.46M | 401.82M | 393.19M | 677.55M | 631.41M | |||||
| Non-Current Assets | |||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 11.80M | 12.32M | 13.40M | 15.21M | 19.38M | 27.07M | 33.80M | 35.34M | 34.99M | 33.80M | 34.04M | 33.25M | 31.44M | 29.48M | 29.34M | 29.05M | 27.60M | 25.99M | 28.41M | 29.93M | |||||
| Other Non-Current Assets | 1.73M | 5.34M | 5.33M | 5.32M | 5.26M | 4.32M | 5.28M | 4.53M | 4.52M | 4.58M | 4.86M | 4.87M | 4.91M | 4.86M | 4.88M | 4.95M | 4.95M | 4.95M | 4.95M | 4.94M | |||||
| Non-Current Assets | 13.53M | 17.66M | 25.64M | 68.01M | 62.37M | 66.50M | 68.47M | 70.51M | 69.19M | 67.54M | 67.71M | 66.22M | 63.87M | 61.29M | 60.92M | 60.12M | 58.02M | 55.47M | 58.88M | 59.76M | |||||
| Assets | 384.05M | 366.33M | 346.00M | 365.06M | 357.60M | 342.39M | 309.03M | 278.62M | 252.10M | 303.75M | 266.75M | 344.11M | 315.08M | 438.73M | 393.20M | 359.59M | 459.84M | 448.66M | 736.43M | 691.16M | |||||
| Liabilities | |||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||
| Accounts Payables | 3.53M | 6.56M | 4.51M | 4.29M | 9.75M | 7.86M | 7.38M | 5.31M | 5.50M | 11.15M | 6.83M | 6.47M | 3.98M | 17.21M | 6.49M | 5.58M | 14.51M | 3.55M | 7.90M | 7.15M | |||||
| Payables | 3.53M | 6.56M | 4.51M | 4.29M | 9.75M | 7.86M | 7.38M | 5.31M | 5.50M | 11.15M | 6.83M | 6.47M | 3.98M | 17.21M | 6.49M | 5.58M | 14.51M | 3.55M | 7.90M | 7.15M | |||||
| Accumulated Expenses | 9.21M | 10.08M | 6.46M | 7.82M | 8.97M | 14.58M | 10.24M | 11.11M | 14.23M | 14.60M | 10.71M | 12.76M | 15.10M | 18.79M | 16.29M | 13.77M | 17.90M | 26.69M | 25.59M | 25.77M | |||||
| Other Accumulated Expenses | 0.84M | 5.02M | 3.84M | 2.46M | 2.91M | 1.67M | 2.16M | 1.95M | 1.30M | 3.35M | 4.42M | ||||||||||||||
| Current Leases | 2.66M | 3.06M | 3.13M | 2.89M | 2.67M | 2.88M | 3.16M | 3.35M | 3.47M | 3.65M | 3.71M | 3.87M | 4.09M | 4.24M | 4.40M | 4.48M | 4.63M | ||||||||
| Current Deferred Revenue | 32.32M | 28.53M | 33.60M | 25.11M | 117.23M | 32.58M | 18.41M | 111.89M | 111.33M | 103.64M | 105.62M | ||||||||||||||
| Total Current Liabilities | 12.74M | 16.64M | 12.49M | 14.77M | 21.79M | 25.57M | 20.52M | 19.09M | 22.61M | 46.59M | 41.29M | 42.35M | 41.64M | 156.95M | 59.22M | 41.85M | 61.44M | 64.21M | 71.04M | 59.66M | |||||
| Non-Current Liabilities | |||||||||||||||||||||||||
| Pension | 2.00M | 5.97M | 2.18M | 2.14M | 2.13M | 6.85M | 1.51M | 1.50M | 1.45M | 12.03M | 2.57M | 2.61M | 2.82M | 3.70M | 3.96M | 4.56M | 4.74M | 5.26M | 5.26M | 5.24M | |||||
| Preferred Stock Liabilities | |||||||||||||||||||||||||
| Non-Current Deferred Tax LiabilityNon-Current Deferred Tax | 11.50M | ||||||||||||||||||||||||
| Operating Leases | 5.46M | 46.09M | 42.59M | 43.87M | 43.27M | 44.37M | 43.52M | 42.88M | 41.84M | 40.88M | 40.05M | 39.00M | 38.00M | 37.04M | 35.93M | 34.79M | 34.58M | 33.36M | |||||||
| Other Non-Current Liabilities | |||||||||||||||||||||||||
| Total Non-Current Liabilities | 101.20M | 99.20M | 93.20M | 99.70M | |||||||||||||||||||||
| Total Liabilities | 14.74M | 18.81M | 20.13M | 63.01M | 66.51M | 70.98M | 65.30M | 64.96M | 67.58M | 124.50M | 114.23M | 119.44M | 109.62M | 215.80M | 118.04M | 91.51M | 214.00M | 215.60M | 214.51M | 203.88M | |||||
| Shareholder's Equity | |||||||||||||||||||||||||
| Common Equity | 369.31M | 347.51M | 325.88M | 302.05M | 291.09M | 271.41M | 243.73M | 213.65M | 184.52M | 179.25M | 152.52M | 224.67M | 205.46M | 222.94M | 275.16M | 268.08M | 245.84M | 233.06M | 521.92M | 487.28M | |||||
| Liabilities and Shareholders Equity | 384.05M | 366.33M | 346.00M | 365.06M | 357.60M | 342.39M | 309.03M | 278.62M | 252.10M | 303.75M | 266.75M | 344.11M | 315.08M | 438.73M | 393.20M | 359.59M | 459.84M | 448.66M | 736.43M | 691.16M | |||||
| Retained Earnings | -98.60M | -122.03M | -146.00M | -172.44M | -199.80M | -230.54M | -262.60M | -297.80M | -332.64M | -365.89M | -397.90M | -428.20M | -452.02M | -438.59M | -391.70M | -404.00M | -431.10M | -477.21M | -521.72M | -565.11M | |||||
| Treasury Shares | 46.63M | 46.68M | 48.37M | 49.32M | 49.36M | 49.59M | 50.07M | 50.14M | 50.20M | 61.33M | 61.38M | 61.51M | 61.51M | 61.72M | 61.79M | 65.54M |